Welcome to the international HTA database

Showing [16732 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	NIHR Horizon Scanning Centre (NIHR HSC)	OncoBEAM RAS CRC for metastatic colorectal cancer
2015	NIHR Health Technology Assessment programme	Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion
2015	NIHR Health Technology Assessment programme	Structured telephone support or telemonitoring programmes for patients with chronic heart failure
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Intracorneal ring segments for keratoconus
2015	Health Quality Ontario (HQO)	Pancreas islet transplantation for patients with type 1 diabetes mellitus: OHTAC recommendation
2015	NIHR Horizon Scanning Centre (NIHR HSC)	myPath Melanoma for the diagnosis of malignant melanoma
2015	NIHR Health Technology Assessment programme	Vaccines for preventing influenza in healthy adults (A060)
2015	Health Quality Ontario (HQO)	Patient perspectives on quality of life with controlled type 1 diabetes mellitus: a systematic review and qualitative meta-synthesis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	P1vital® eHealth Emotional Test Battery (eH-ETB) for early detection of treatment effect in depression
2015	Health Quality Ontario (HQO)	Transient elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	ROCA® for the diagnosis of ovarian cancer
2015	NIHR Health Technology Assessment programme	Interventions for promoting reintegration and reducing harmful behaviour and lifestyles in street-connected children and young people
2015	Health Quality Ontario (HQO)	Transient elastography for assessment of liver fibrosis and steatosis: OHTAC recommendation
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Texture analysis of Radiological images (TexRAD) for lung cancer assessment
2015	Health Quality Ontario (HQO)	Transient elastography and controlled attenuation parameter for diagnosing liver fibrosis and steatosis in Ontario: an economic analysis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Multistatic Array processing for Radiowave Image Acquisition (MARIA) for detection of breast tumours
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Orthotics and prosthetics workforce planning
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Fully bioresorbable scaffolds for coronary artery disease: systematic review]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	RhythmView™ system for cardiac arrhythmias
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Defibrotide for hepatic veno-occlusive disease
2015	NIHR Horizon Scanning Centre (NIHR HSC)	OncAlert® and SensoDX OraTech™ for the diagnosis of oral cancer
2015	NIHR Health Technology Assessment programme	Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data)
2015	NIHR Horizon Scanning Centre (NIHR HSC)	ClearSight™ MRI for breast cancer lumpectomy
2015	NIHR Health Technology Assessment programme	Tonsillectomy or adenotonsillectomy versus non-surgical management for sleep-disordered breathing in children
2015	NIHR Public Health Research (PHR) programme	Preventing alcohol misuse in young people: an exploratory cluster randomised controlled trial of the Kids, Adults Together (KAT) programme
2015	NIHR Health Technology Assessment programme	Interventions for the treatment of oral and oropharyngeal cancers: immunotherapy
2015	NIHR Health Services and Delivery Research programme	What evidence is there on the effectiveness of different models of delivering urgent care? A rapid review
2015	NIHR Health Services and Delivery Research programme	Collective action for knowledge mobilisation: a realist evaluation of the Collaborations for Leadership in Applied Health Research and Care
2015	NIHR Health Technology Assessment programme	Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials)
2015	NIHR Health Technology Assessment programme	Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
2015	Agency for Healthcare Research and Quality (AHRQ)	Management and outcomes of binge-eating disorder
2015	NIHR Health Technology Assessment programme	Active Treatment for Idiopathic Adolescent Scoliosis (ACTIvATeS): a feasibility study
2015	NIHR Health Technology Assessment programme	Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation
2015	Agency for Healthcare Research and Quality (AHRQ)	Nonpharmacological versus pharmacological treatments for adult patients with major depressive disorder
2015	NIHR Health Technology Assessment programme	A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
2015	NIHR Health Services and Delivery Research programme	Integration and continuity of primary care: polyclinics and alternatives - a patient-centred analysis of how organisation constrains care co-ordination
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bevacizumab (Avastin®) in combination with chemotherapy as second-line therapy for HER2-negative, locally recurrent or metastatic breast cancer that has progressed after first-line treatment with bevacizumab plus chemotherapy
2015	National Institute for Health and Care Excellence (NICE)	Repetitive transcranial magnetic stimulation for depression. NICE interventional procedures guidance 542
2015	NIHR Health Technology Assessment programme	Systematic review of tools to measure outcomes for young children with autism spectrum disorder
2015	NIHR Health Services and Delivery Research programme	Research utilisation and knowledge mobilisation in the commissioning and joint planning of public health interventions to reduce alcohol-related harms: a qualitative case design using a cocreation approach
2015	National Institute for Health and Care Excellence (NICE)	Joint distraction for ankle osteoarthritis. NICE interventional procedures guidance 538
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Nivolumab (Nivolumab BMS®) for the second-line therapy of metastatic squamous non-small cell lung cancer
2015	National Institute for Health and Care Excellence (NICE)	Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma. NICE interventional procedures guidance 539
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Ramucirumab in combination with paclitaxel as second-line treatment for adult patients with advanced gastric or gastro-oesophageal junction carcinoma
2015	National Institute for Health and Care Excellence (NICE)	Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease. NICE interventional procedures guidance 540
2015	NIHR Health Technology Assessment programme	A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
2015	NIHR Health Technology Assessment programme	A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)
2015	NIHR Health Services and Delivery Research programme	Family-Reported Experiences Evaluation (FREE) study: a mixed-methods study to evaluate families' satisfaction with adult critical care services in the NHS
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Carfilzomib (Kyprolis®) for patients with relapsed multiple myeloma who have received one to three prior lines of therapy
2015	National Institute for Health and Care Excellence (NICE)	Insertion of a subretinal prosthesis system for retinitis pigmentosa. NICE interventional procedures guidance 537
2015	NIHR Health Services and Delivery Research programme	Delivering patient choice in clinical practice: a conversation analytic study of communication practices used in neurology clinics to involve patients in decision-making
2015	Health Information and Quality Authority (HIQA)	Health technology assessment of a selective BCG vaccination programme
2015	National Institute for Health and Care Excellence (NICE)	Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes. NICE interventional procedures guidance 534
2015	NIHR Health Services and Delivery Research programme	Multisite implementation of trained volunteer doula support for disadvantaged childbearing women: a mixed-methods evaluation
2015	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care
2015	Norwegian Institute of Public Health (NIPH)	A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients
2015	National Institute for Health and Care Excellence (NICE)	Living-donor liver transplantation. NICE interventional procedures guidance 535
2015	Health Quality Ontario (HQO)	Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015	Agency for Healthcare Research and Quality (AHRQ)	Catheter ablation for treatment of atrial fibrillation
2015	Health Information and Quality Authority (HIQA)	Health technology assessment of the use of information technology for early warning and clinical handover systems
2015	National Institute for Health and Care Excellence (NICE)	Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. NICE interventional procedures guidance 536
2015	Health Quality Ontario (HQO)	Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015	NIHR Health Services and Delivery Research programme	A systematic review and metaethnography to identify how effective, cost-effective, accessible and acceptable self-management support interventions are for men with long-term conditions (SELF-MAN)
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pembrolizumab (Keytruda®) for the treatment of advanced melanoma
2015	National Institute for Health and Care Excellence (NICE)	Implanting a baroreceptor stimulation device for resistant hypertension. NICE interventional procedures guidance 533
2015	Health Quality Ontario (HQO)	Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015	NIHR Health Services and Delivery Research programme	Integration and continuity of primary care: polyclinics and alternatives - a patient-centred analysis of how organisation constrains care co-ordination
2015	Norwegian Institute of Public Health (NIPH)	Cost-effectiveness of HPV-vaccination of boys aged 12 in a Norwegian setting
2015	National Institute for Health and Care Excellence (NICE)	Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer. NICE interventional procedures guidance 532
2015	NIHR Health Services and Delivery Research programme	The Birthplace in England national prospective cohort study: further analyses to enhance policy and service delivery decision-making for planned place of birth
2015	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis of right lower quadrant pain and suspected acute appendicitis
2015	National Institute for Health and Care Excellence (NICE)	Preoperative high dose rate brachytherapy for rectal cancer. NICE interventional procedures guidance 531
2015	Blue Cross Blue Shield Association (BCBS)	Special report: early intensive behavioral intervention and other behavioral interventions for autism spectrum disorder
2015	NIHR Health Services and Delivery Research programme	Establishing and implementing best practice to reduce unplanned admissions in those aged 85 years and over through system change [Establishing System Change for Admissions of People 85+ (ESCAPE 85+)]: a mixed-methods case study approach
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Raltegravir (Isentress®)
2015	National Institute for Health and Care Excellence (NICE)	Transcranial direct current stimulation (tDCS) for depression. NICE interventional procedures guidance 530
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eculizumab (Soliris®)
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sucroferric oxyhydroxide (Velphoro®)
2015	National Institute for Health and Care Excellence (NICE)	Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section. NICE interventional procedures guidance 528
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ledipasvir/sofosbuvir (Harvoni®)
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tinzaparin sodium (Innohep®)
2015	National Institute for Health and Care Excellence (NICE)	Joint distraction for knee osteoarthritis without alignment correction. NICE interventional procedures guidance 529
2015	National Institute for Health and Care Excellence (NICE)	Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C. NICE medical technologies guidance 27
2015	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]
2015	University of York	Supporting self-management: helping people manage long-term conditions
2015	NIHR Health Technology Assessment programme	The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Denosumab (Xgeva®)
2015	National Institute for Health and Care Excellence (NICE)	Suture fixation of acute disruption of the distal tibiofibular syndesmosis. NICE interventional procedures guidance 521
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tedizolid phosphate (Sivextro®)
2015	National Institute for Health and Care Excellence (NICE)	Ultrasound-enhanced, catheter-directed thrombolysis for deep vein thrombosis. NICE interventional procedures guidance 523
2015	University of York	Promoting patient-centred care planning consultations
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Insulin glargine (Abasaglar®)
2015	National Institute for Health and Care Excellence (NICE)	Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism. NICE interventional procedures guidance 524
2015	National Institute for Health and Care Excellence (NICE)	Tegaderm CHG securement dressing for vascular access sites in critically ill adults. NICE medical technologies guidance 25
2015	NIHR Health Technology Assessment programme	Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study
2015	University of York	Evidence to inform the commissioning of social prescribing
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Insulin degludec/liraglutide (Xultophy®)
2015	Health Information and Quality Authority (HIQA)	Health technology assessment of chronic disease self-management support interventions
2015	National Institute for Health and Care Excellence (NICE)	Electrotherapy for the treatment of haemorrhoids. NICE interventional procedures guidance 525
2015	NIHR Health Technology Assessment programme	Elosulfase alfa for treating mucopolysaccharidosis type IVA [ID744]